NCT02711202 2026-04-13
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Phase NA Completed
Institute for Clinical and Experimental Medicine
National Cancer Center, Korea
Fujian Cancer Hospital
Tel-Aviv Sourasky Medical Center
The Royal Wolverhampton Hospitals NHS Trust
Lokman Hekim University
Dr. Lutfi Kirdar Kartal Training and Research Hospital
NHS Lothian